The Discounted Cash Flow (DCF) valuation of Oncternal Therapeutics Inc (ONCT) is (631.06) USD. With the latest stock price at 0.53 USD, the upside of Oncternal Therapeutics Inc based on DCF is -119936.8%.
Based on the latest price of 0.53 USD and our DCF valuation, Oncternal Therapeutics Inc (ONCT) is a sell. selling ONCT stocks now will result in a potential gain of 119936.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 7.1% | 6.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (4,045.68) - (349.67) | (631.06) |
| Upside | -768365.2% - -66501.2% | -119936.8% |